
Join to View Full Profile
20 Duke Medicine CircleDurham, NC 27710
Phone+1 919-668-6608
Dr. Uronis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Hope Uronis is an oncologist in Durham, NC and is affiliated with multiple hospitals in the area, including Duke University Hospital and Duke Regional Hospital. She received her medical degree from University at Buffalo School of Medicine and has been in practice 17 years. She specializes in gastrointestinal cancer and hematologic oncology and is experienced in hematologic oncology and gastrointestinal oncology. She has more than 60 publications and over 500 citings.
Education & Training
- Duke University HospitalFellowship, Hematology and Medical Oncology, 2003 - 2007
- Duke University HospitalResidency, Internal Medicine, 2000 - 2003
- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2000
Certifications & Licensure
- NC State Medical License 2000 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma Start of enrollment: 2007 Feb 01
- A Phase I/Expansion Study of Dasatinib Start of enrollment: 2007 Apr 01
- QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer Start of enrollment: 2012 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- ASO Author Reflections: Towards Personalized Cancer Therapy: The Role of ctDNA as a Biomarker in Patients with Unresectable Colorectal Liver Metastases Treated with He...Annie Liu, John Strickler, Hope Uronis, Michael E Lidsky
Annals of Surgical Oncology. 2025-10-01 - Circulating Tumor DNA as a Novel Prognostic Biomarker of Therapeutic Efficacy in Patients with Unresectable Colorectal Liver Metastases Treated with Hepatic Arterial I...Annie Liu, Ellery H Reason, Brittany G Sullivan, Benjamin Wildman-Tobriner, John H Strickler
Annals of Surgical Oncology. 2025-10-01 - DKN-01 and tislelizumab as second-line therapy in DKK1-high gastroesophageal adenocarcinoma: DisTinGuish trial part B.Keun-Wook Lee, Devalingam Mahalingam, Byoung Yong Shim, In-Ho Kim, Do-Youn Oh
Nature Communications. 2025-07-10
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: